Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis

Overview of attention for article published in Frontiers in immunology, April 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 1 patent

Readers on

mendeley: 48 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

MARKERS OF DISEASE PROGNOSIS IN MULTIPLE SCLEROSIS

Application EP-3894866-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.